Radiotracer studies
The use of radioisotopes, radiolabeled molecules and radioactive particles in conjunction with a range of quantitative imaging spectroscopy and radiation counting methods.
Showing 261 - 280 of 868 results
Australian Synchrotron celebrates 20,000 research partnerships
ANSTO's National Science Week events
National Science Week is a time to celebrate science and the important role national science agencies like ANSTO play in delivering outcomes that benefit all Australians.
End of an era for Australia’s first nuclear reactor
Progress on advanced prostate cancer
Updated results show radiation therapy using lutetium-177 improved survival in advanced prostate cancer.
Using neutrons to show weak spots in turbines, railway lines and pipes
License to produce Lutetium-177 for clinical trials
ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.
Connect with ANSTO's Women in STEM
Read about an ANSTO scientist and their work to prepare for a school project or interview.
Potential true theranostic agent for cancer produced
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Clip Day 2024 Accommodation, Meals and Transport
Gentech Generator
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
Learn from Australia's nuclear experts
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
Statement of Expectations
On the 10th of October 2025, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
Meet some of the women from the history of ANSTO who were pioneers in their time
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
ANSTO shares award
Paper on redefinition of the kilogram receives international award
Watershed moment for nuclear medicine and ANSTO
ANSTO participates in nuclear medicine congress
Development of radiotracers
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
Strategic relationship agreement with the Australian National University
ANSTO has signed a strategic agreement with the Australian National University and sets the relationship between the two organisations, who collaborate on important projects, such as the fusion energy project ITER and space research, well into the future.
Sika operation and research agreement renewed
Agreement extends Taiwan’s National Synchrotron Radiation Research Center’s operation of neutron scattering instrument at ANSTO